DE60322733D1 - Cap-bindungsprotein - Google Patents

Cap-bindungsprotein

Info

Publication number
DE60322733D1
DE60322733D1 DE60322733T DE60322733T DE60322733D1 DE 60322733 D1 DE60322733 D1 DE 60322733D1 DE 60322733 T DE60322733 T DE 60322733T DE 60322733 T DE60322733 T DE 60322733T DE 60322733 D1 DE60322733 D1 DE 60322733D1
Authority
DE
Germany
Prior art keywords
agent
polypeptide
screening
improving
insulin resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322733T
Other languages
English (en)
Inventor
Tamaki Oda
Hideki Endoh
Yoshitaka Ueda
Kazunori Inabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DE60322733D1 publication Critical patent/DE60322733D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60322733T 2002-10-11 2003-10-09 Cap-bindungsprotein Expired - Lifetime DE60322733D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002298549 2002-10-11
PCT/JP2003/012968 WO2004033688A1 (ja) 2002-10-11 2003-10-09 Ｃａｐ結合蛋白質

Publications (1)

Publication Number Publication Date
DE60322733D1 true DE60322733D1 (de) 2008-09-18

Family

ID=32089315

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322733T Expired - Lifetime DE60322733D1 (de) 2002-10-11 2003-10-09 Cap-bindungsprotein

Country Status (9)

Country Link
US (1) US7141650B2 (de)
EP (1) EP1557465B1 (de)
JP (1) JP4419077B2 (de)
AT (1) ATE403725T1 (de)
AU (1) AU2003271150A1 (de)
CA (1) CA2501875A1 (de)
DE (1) DE60322733D1 (de)
ES (1) ES2309332T3 (de)
WO (1) WO2004033688A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833716B2 (en) 2006-06-06 2010-11-16 Gen-Probe Incorporated Tagged oligonucleotides and their use in nucleic acid amplification methods
US20090038024A1 (en) * 2007-06-19 2009-02-05 The Regents Of The University Of California Cap/sorbs1 and diabetes
US11865121B2 (en) 2016-02-11 2024-01-09 Nutrition21, LLC Chromium containing compositions for improving health and fitness

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003023002A2 (en) * 2001-09-07 2003-03-20 Curagen Corporation Novel human proteins, polynucleotides encoding them and methods of using the same

Also Published As

Publication number Publication date
CA2501875A1 (en) 2004-04-22
ES2309332T3 (es) 2008-12-16
AU2003271150A1 (en) 2004-05-04
US20060008857A1 (en) 2006-01-12
EP1557465A4 (de) 2006-06-07
JP4419077B2 (ja) 2010-02-24
WO2004033688A1 (ja) 2004-04-22
ATE403725T1 (de) 2008-08-15
EP1557465B1 (de) 2008-08-06
EP1557465A1 (de) 2005-07-27
US7141650B2 (en) 2006-11-28
JPWO2004033688A1 (ja) 2006-02-09

Similar Documents

Publication Publication Date Title
WO2005019256A3 (en) Muteins of tear lipocalin
AU2001254624A1 (en) Human coagulation factor vii variants
SG161234A1 (en) A method and composition for nutritionally improving glucose control and insulin action
BRPI0410164A (pt) composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano
WO2010014946A3 (en) Halogen-stabilized insulin
WO2007110231A3 (en) MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
DE60330781D1 (de) Anwendung von lactobacillus zur herstellung von exopolysacchariden in nahrungsmittel und pharmazeutische zusammensetzungen
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
ATE490984T1 (de) Methode zur produktion und evaluierung der zytotoxizität von kir2dl nk-rezeptor antikörpern
CY1107470T1 (el) Συνθεσεις γλυκοσυλιωμενης λεπτινης και σχετικες μεθοδοι
AU2003266214A1 (en) Human coagulation factor vii polypeptides
AU2003903124A0 (en) Analogues of heteromeric proteins
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
EA200600996A1 (ru) Композиция для полезного воздействия на кожу с использованием ключевых промежуточных продуктов клеточного метаболизма
ES2195555T3 (es) Empleo de composiciones para proporcionar glutamina.
DE60322733D1 (de) Cap-bindungsprotein
EP0992586A3 (de) Extrazelluläre Matrixproteine mit modifizierten Aminosäuren
WO2007015918A3 (en) Novel biologically active peptides and their new uses
WO2007027092A3 (en) Oral composition for moisturising skin
AU2003289186A1 (en) PROTEIN BINDING TO Akt2
WO2004071443A3 (en) Methods and compositions for modulating stem cells
WO2003082897A3 (en) Synthetic active peptide fragments
ATE337776T1 (de) Kosmetische oder dermatologische cremezubereitung,deren herstellung und verwendung
WO2006116486A3 (en) Composition and method for reducing the appearance for cellulite
BRPI0517004A (pt) produto alimentìcio contendo um ou vários microorganismos vivos e pelo menos um ingrediente alimentìcio bioativo de interesse, processo de preparação do mesmo e utilizações de um produto alimentìcio e de pelo menos um ingrediente alimentìcio isca

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: UEDA, YOSHITAKA, CHUO-KU, TOKYO, JP

Inventor name: INABE, KAZUNORI, CHUO-KU, TOKYO, JP

Inventor name: ODA, TAMAKI, CHUO-KU, TOKYO, JP

Inventor name: ENDOH, HIDEKI, CHUO-KU, TOKYO, JP

8364 No opposition during term of opposition